AIM
ACOR

Acrospire Investment Management’s Acorda Therapeutics ACOR Stock Holding History

Acrospire Investment Management’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Hold
0
– -$1K – 1597
2017
Q2 		– Sell
-32
Closed -$63.4K – 2113
2017
Q1 		$81K Sell
32
-3
-9% -$8.63K 0.07% 476
2016
Q4 		$79K Buy
35
+12
+52% +$28.5K 0.03% 1092
2016
Q3 		$58K Sell
23
-15
-39% -$44.8K 0.04% 962
2016
Q2 		$115K Buy
38
+18
+90% +$58.5K 0.09% 339
2016
Q1 		$63K Buy
+20
New +$83K 0.04% 727

Other funds holding ACOR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Acrospire Investment Management's ACOR Position: Q3 2017 in Review

Acrospire Investment Management held its Acorda Therapeutics (ACOR) position steady in Q3 2017 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1597.

Acrospire Investment Management first reported a position in ACOR in Q1 2016 and has held it in 5 quarters since. The position peaked at $115K in Q2 2016. 152 funds tracked by Wall St. Rank hold ACOR as of Q3 2017.

  • Acrospire Investment Management held 0 shares of Acorda Therapeutics worth $0 as of Q3 2017.
  • Acrospire Investment Management left its Acorda Therapeutics share count unchanged in Q3 2017.
  • Acorda Therapeutics made up ﹤0.01% of Acrospire Investment Management's portfolio in Q3 2017, its #1597 holding.
  • Acrospire Investment Management first reported a position in Acorda Therapeutics in Q1 2016 and has held it in 5 quarters since.
  • Acrospire Investment Management's Acorda Therapeutics position peaked at $115K in Q2 2016.
  • 152 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.